Cargando…
Derivate Isocorydine (d-ICD) Suppresses Migration and Invasion of Hepatocellular Carcinoma Cell by Downregulating ITGA1 Expression
In our previous studies, we found that isocorydine (ICD) could be a potential antitumor agent in hepatocellular carcinoma (HCC). Derivate isocorydine (d-ICD), a more effective antitumor agent, has been demonstrated to inhibit proliferation and drug resistance in HCC. In order to investigate the pote...
Autores principales: | Liu, Xiaoqin, Tian, Hua, Li, Hong, Ge, Chao, Zhao, Fangyu, Yao, Ming, Li, Jinjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372530/ https://www.ncbi.nlm.nih.gov/pubmed/28264467 http://dx.doi.org/10.3390/ijms18030514 |
Ejemplares similares
-
An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma
por: Li, Meng, et al.
Publicado: (2015) -
Isocorydine Inhibits Cell Proliferation in Hepatocellular Carcinoma Cell Lines by Inducing G2/M Cell Cycle Arrest and Apoptosis
por: Sun, Hefen, et al.
Publicado: (2012) -
CD24 isoform a promotes cell proliferation, migration and invasion and is downregulated by EGR1 in hepatocellular carcinoma
por: Li, Liangyu, et al.
Publicado: (2019) -
Isocorydine Derivatives and Their Anticancer Activities
por: Zhong, Mei, et al.
Publicado: (2014) -
Effects of 8-Amino-Isocorydine, a Derivative of Isocorydine, on Gastric Carcinoma Cell Proliferation and Apoptosis
por: Song, Lei, et al.
Publicado: (2021)